VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CYH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CYHCommunity Health Systems, Inc.
$2.21$312M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCYHQuarterly Financials

Community Health Systems, Inc. (CYH) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Community Health Systems, Inc. (CYH) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CYH Income Statement

Quarterly statement

CYH Income Statement

Community Health Systems, Inc. (CYH) annual income statement — 27-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue2.76B4.06B12.16B3.11B3.09B3.13B3.16B3.27B3.09B3.14B3.14B3.18B3.09B3.12B3.11B3.14B3.02B2.93B3.11B3.23B
Revenue Growth %-10.69%29.65%284.87%-4.87%-0.1%-0.22%0.61%2.61%0.13%0.8%1.03%1.27%2.02%6.17%-0.1%-2.81%-2.89%-2.43%3.25%3.65%
Cost of Goods Sold2.6B1.24B413M7.29B460M1.8B1.86B1.87B1.83B1.81B1.85B1.87B1.83B1.84B1.87B1.86B1.84B1.78B1.82B1.86B
COGS % of Revenue94.2%30.45%3.4%234.58%14.9%57.33%58.91%57.3%59.16%57.71%59.08%58.74%59.2%59.13%60.23%59.07%60.96%60.74%58.63%57.47%
Gross Profit160M2.83B11.74B-4.18B2.63B1.34B1.3B1.39B1.26B1.33B1.28B1.31B1.26B1.27B1.24B1.29B1.18B1.15B1.29B1.38B
Gross Margin %5.8%69.55%96.6%-134.58%85.1%42.67%41.09%42.7%40.84%42.29%40.92%41.26%40.8%40.87%39.77%40.93%39.04%39.26%41.37%42.53%
Gross Profit Growth %-93.91%111.29%804.85%-399.86%108.16%0.68%1.01%6.17%0.24%4.32%3.96%2.1%6.6%10.5%-3.96%-6.47%-5.52%-7.17%5.58%11.07%
Operating Expenses2.19B2.44B10.1B6.77B2.38B825M1.01B1.12B1.47B1.09B1.05B986M1.09B1.03B1.03B1.06B977M1.03B1.02B951M
OpEx % of Revenue79.43%59.97%83.08%218.09%77.23%26.33%32.1%34.18%47.48%34.71%33.57%30.99%35.19%32.97%33.01%33.64%32.3%35.21%32.69%29.42%
Selling, General & Admin1.27B1.24B10.69B-1.56B1.42B74M68M75M73M73M77M79M79M80M81M81M80M78M77M77M
SG&A % of Revenue46.25%30.45%87.94%-50.39%46.1%2.36%2.15%2.3%2.36%2.32%2.45%2.48%2.56%2.57%2.61%2.58%2.64%2.66%2.48%2.38%
Research & Development0000000000080M00085M0000
R&D % of Revenue-----------2.51%---2.71%----
Other Operating Expenses1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income160M389M1.64B-10.95B243M512M284M278M-205M238M231M327M173M246M210M229M204M119M270M424M
Operating Margin %5.8%9.58%13.52%-352.67%7.87%16.34%8.99%8.51%-6.63%7.58%7.36%10.28%5.61%7.9%6.76%7.29%6.74%4.06%8.68%13.11%
Operating Income Growth %-34.16%-24.02%478.87%-4040.29%218.54%115.13%22.94%-14.98%-218.5%-3.25%10%42.79%-15.2%106.72%-22.22%-45.99%-40%-62.1%-17.18%-2.75%
EBITDA266M497M1.76B-10.85B351M618M389M407M-89M364M346M368M302M369M342M280M341M252M398M448M
EBITDA Margin %9.65%12.24%14.46%-349.16%11.37%19.73%12.31%12.47%-2.88%11.59%11.02%11.57%9.79%11.85%11%8.91%11.27%8.59%12.79%13.86%
EBITDA Growth %-24.22%-19.58%351.93%-2764.62%494.38%69.78%12.43%10.6%-129.47%-1.35%1.17%31.43%-11.44%46.43%-14.07%-37.5%-28.36%-43.75%-14.22%0.22%
D&A (Non-Cash Add-back)106M108M114M109M108M106M105M129M116M126M115M41M129M123M132M51M137M133M128M24M
EBIT160M217M3.3B442M214M273M260M285M62M248M248M249M199M233M188M244M136M111M229M378M
Net Interest Income-201M-206M-213M-221M-216M-214M-219M-217M-216M-216M-211M-209M-208M-207M-207M-206M-217M-218M-217M-219M
Interest Income00000000000000000000
Interest Expense201M206M213M221M216M214M219M217M216M216M211M209M208M207M207M205M217M218M217M220M
Other Income/Expense-213M-209M-2.52B11.18B-245M-74M-217M-214M-214M-188M-209M-134M-206M-206M-204M96M-134M-217M-217M-203M
Pretax Income-53M180M-880M221M-2M438M67M64M-419M50M22M193M-33M40M6M325M70M-98M53M221M
Pretax Margin %-1.92%4.43%-7.24%7.12%-0.06%13.98%2.12%1.96%-13.56%1.59%0.7%6.07%-1.07%1.28%0.19%10.34%2.31%-3.34%1.7%6.84%
Income Tax-3M76M102M61M-173M118M42M92M-64M24M28M107M19M38M26M-121M70M200M23M-2M
Effective Tax Rate %5.66%42.22%-11.59%27.6%8650%26.94%62.69%143.75%15.27%48%127.27%55.44%-57.58%95%433.33%-37.23%100%-204.08%43.4%-0.9%
Net Income-86M70M-610M110M130M282M-13M-70M-391M-13M-41M47M-91M-38M-51M415M-42M-326M-1M178M
Net Margin %-3.12%1.72%-5.02%3.54%4.21%9%-0.41%-2.14%-12.65%-0.41%-1.31%1.48%-2.95%-1.22%-1.64%13.21%-1.39%-11.11%-0.03%5.51%
Net Income Growth %-166.15%-75.18%-4592.31%257.14%133.25%2269.23%68.29%-248.94%-329.67%65.79%19.61%-88.67%-116.67%88.34%-5000%133.15%-137.84%-5533.33%98.44%-42.77%
Net Income (Continuing)-50M104M-982M160M171M320M25M-28M-355M26M-6M86M-52M2M-20M446M0-298M30M223M
Discontinued Operations00000000000000000000
Minority Interest555M226M489M557M551M533M594M597M553M562M550M568M570M669M654M633M608M582M573M562M
EPS (Diluted)-0.630.51-4.520.820.962.09-0.10-0.53-2.95-0.10-0.310.35-0.70-0.29-0.393.18-0.33-2.530.231.34
EPS Growth %-165.63%-75.6%-4521.68%254.72%132.54%2228.31%68.45%-251.43%-321.43%66.14%20.51%-88.99%-112.12%88.54%-269.57%137.31%-138.82%-6425%145.1%-47.86%
EPS (Basic)-0.630.52-4.570.820.972.11-0.10-0.53-2.95-0.10-0.310.35-0.70-0.29-0.403.21-0.33-2.530.231.40
Diluted Shares Outstanding136M136M135M135M135M135M132.88M132M132.38M132.34M131.27M132M130.7M130.66M129.69M130M129.14M129.1M128M133M
Basic Shares Outstanding136M135M134M134M133M134M132.88M132M132.38M132.34M131.27M131M130.7M130.66M127.5M129M129.14M129.1M127.82M127M
Dividend Payout Ratio--------------------